These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 21219977

  • 1. Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice.
    Ezoe H, Akeda Y, Piao Z, Aoshi T, Koyama S, Tanimoto T, Ishii KJ, Oishi K.
    Vaccine; 2011 Feb 17; 29(9):1754-61. PubMed ID: 21219977
    [Abstract] [Full Text] [Related]

  • 2. Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice.
    Oma K, Zhao J, Ezoe H, Akeda Y, Koyama S, Ishii KJ, Kataoka K, Oishi K.
    Vaccine; 2009 May 21; 27(24):3181-8. PubMed ID: 19446189
    [Abstract] [Full Text] [Related]

  • 3. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.
    Yamamoto M, Briles DE, Yamamoto S, Ohmura M, Kiyono H, McGhee JR.
    J Immunol; 1998 Oct 15; 161(8):4115-21. PubMed ID: 9780183
    [Abstract] [Full Text] [Related]

  • 4. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 5. Effective protection against secondary pneumococcal pneumonia by oral vaccination with attenuated Salmonella delivering PspA antigen in mice.
    Seo SU, Kim JJ, Yang H, Kwon HJ, Yang JY, Curtiss Iii R, Kweon MN.
    Vaccine; 2012 Nov 06; 30(48):6816-23. PubMed ID: 23000127
    [Abstract] [Full Text] [Related]

  • 6. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B, Chen X, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Wu Y.
    Microb Pathog; 2018 Oct 06; 123():115-119. PubMed ID: 29959043
    [Abstract] [Full Text] [Related]

  • 7. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC, Bosarge JR, Quin LR, McDaniel LS.
    Vaccine; 2006 Jul 17; 24(29-30):5755-61. PubMed ID: 16759765
    [Abstract] [Full Text] [Related]

  • 8. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 9. Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A.
    Hotomi M, Kono M, Hollingshead SK, Briles DE, Yamanaka N.
    Adv Otorhinolaryngol; 2011 Jun 28; 72():121-5. PubMed ID: 21865708
    [Abstract] [Full Text] [Related]

  • 10. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
    Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH.
    J Infect Dis; 2003 Aug 01; 188(3):339-48. PubMed ID: 12870114
    [Abstract] [Full Text] [Related]

  • 11. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
    Ferreira DM, Oliveira ML, Moreno AT, Ho PL, Briles DE, Miyaji EN.
    Microb Pathog; 2010 Jun 01; 48(6):205-13. PubMed ID: 20206678
    [Abstract] [Full Text] [Related]

  • 12. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 01; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
    Coats MT, Benjamin WH, Hollingshead SK, Briles DE.
    Vaccine; 2005 Jul 21; 23(33):4257-62. PubMed ID: 16005736
    [Abstract] [Full Text] [Related]

  • 14. Humoral immune response of a pneumococcal conjugate vaccine: capsular polysaccharide serotype 14-Lysine modified PspA.
    Santamaria R, Goulart C, Perciani CT, Barazzone GC, Carvalho R, Gonçalves VM, Leite LC, Tanizaki MM.
    Vaccine; 2011 Nov 03; 29(47):8689-95. PubMed ID: 21906649
    [Abstract] [Full Text] [Related]

  • 15. Protection against systemic fatal pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A (PspA).
    Katsurahara T, Hotomi M, Yamauchi K, Billal DS, Yamanaka N.
    J Infect Chemother; 2008 Dec 03; 14(6):393-8. PubMed ID: 19089550
    [Abstract] [Full Text] [Related]

  • 16. Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae.
    Fukuyama Y, King JD, Kataoka K, Kobayashi R, Gilbert RS, Oishi K, Hollingshead SK, Briles DE, Fujihashi K.
    J Immunol; 2010 Aug 01; 185(3):1755-62. PubMed ID: 20585031
    [Abstract] [Full Text] [Related]

  • 17. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.
    Infect Immun; 2012 Mar 01; 80(3):1166-80. PubMed ID: 22158740
    [Abstract] [Full Text] [Related]

  • 18. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB, Carter AT, Hitchin E, Wells JM.
    J Infect Dis; 2007 Jan 15; 195(2):185-93. PubMed ID: 17191163
    [Abstract] [Full Text] [Related]

  • 19. A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.
    Uraki R, Piao Z, Akeda Y, Iwatsuki-Horimoto K, Kiso M, Ozawa M, Oishi K, Kawaoka Y.
    J Infect Dis; 2015 Dec 15; 212(12):1939-48. PubMed ID: 26123562
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
    Shim DH, Ko HJ, Volker G, Potter AA, Mutwiri G, Babiuk LA, Kweon MN.
    Vaccine; 2010 Mar 08; 28(11):2311-7. PubMed ID: 20060944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.